Literature DB >> 18208409

Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies.

Sheila F O'Brien1, Wenli Fan, Guoliang Xi, Qi-Long Yi, Mindy Goldman, Margaret A Fearon, Claire Infante-Rivard, Jo Anne Chiavetta, Bernard Willems, David Pi, Margaret Fast, Gilles Delage.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) rates have decreased steadily in first-time donors in Canada since testing was implemented but reasons are unclear. A description of factors that may have played a role in this decline is reported. STUDY DESIGN AND METHODS: Descriptive analysis of first-time blood donors by HCV positivity status and year (1993--2006), sex, and age was carried out. HCV-positive first-time donors and matched controls participated in a confidential scripted telephone interview about risk factors in 1993 through 1994 and in 2005 through 2006, and risk factors independently predicting HCV positivity were determined with multiple logistic regression.
RESULTS: HCV-positive donations occurred most frequently in donors born between 1945 and 1964 and decreased in this birth cohort over time (p < 0.01). At present, most first-time donors (74%) are born after 1964. History of intravenous drug use, sex with an intravenous drug user, blood transfusion, and tattoo independently predicted (p < 0.01) HCV positivity in both periods (1993--1994 and 2005--2006).
CONCLUSION: Most HCV-positive donors were born between 1945 and 1964, and the decline in HCV rates is associated primarily with this birth cohort. The key risk factors predicting HCV positivity did not change over the 13 years of the study. With approximately two-thirds of HCV-positive Canadians in the general population having been tested for HCV, potential donors may be aware of their HCV status and be likely to self-defer. This, and an increasing proportion of first-time donors born after 1964, may contribute to declining HCV rates in first-time donors.

Entities:  

Mesh:

Year:  2008        PMID: 18208409     DOI: 10.1111/j.1537-2995.2007.01618.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  13 in total

1.  The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models.

Authors:  Yongshui Fu; Wenjie Xia; Yizhong Wang; Linwei Tian; Oliver G Pybus; Ling Lu; Kenrad Nelson
Journal:  Transfusion       Date:  2010-04-23       Impact factor: 3.157

2.  Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index.

Authors:  Edward L Murphy; Junyong Fang; Yongling Tu; Ritchard Cable; Christopher D Hillyer; Ronald Sacher; Darrell Triulzi; Jerome L Gottschall; Michael P Busch
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

3.  A Canadian screening program for hepatitis C: is now the time?

Authors:  Hemant A Shah; Jenny Heathcote; Jordan J Feld
Journal:  CMAJ       Date:  2013-09-30       Impact factor: 8.262

4.  Are donors in Canada compliant with deferral for tattoos and piercing?

Authors:  Sheila F O'brien; Guoliang Xi; Wenli Fan; Qi-Long Yi; Lori Osmond; Gilles Delage; Mindy Goldman
Journal:  Blood Transfus       Date:  2013-01-02       Impact factor: 3.443

5.  Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.

Authors:  Newaz Hossain; Bharat Puchakayala; Pushpjeet Kanwar; Siddharth Verma; George Abraham; Zhanna Ivanov; Muhammad Obaid Niaz; Smruti R Mohanty
Journal:  Dig Dis Sci       Date:  2017-09-14       Impact factor: 3.199

Review 6.  Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.

Authors:  Rania A Tohme; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

7.  Historical trends and projected hospital admissions for chronic hepatitis C infection in Canada: a birth cohort analysis.

Authors:  Dena L Schanzer; Dana Paquette; Lisa M Lix
Journal:  CMAJ Open       Date:  2014-07-22

8.  Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting.

Authors:  W N Southern; M-L Drainoni; B D Smith; C L Christiansen; D McKee; A L Gifford; C M Weinbaum; D Thompson; E Koppelman; S Maher; A H Litwin
Journal:  J Viral Hepat       Date:  2010-05-20       Impact factor: 3.728

9.  Canadian blood suppliers: An expanding role in public health surveillance?

Authors:  Sheila F O'Brien; Steven J Drews; Antoine Lewin; Carla Osiowy; Michael A Drebot; Christian Renaud
Journal:  Can Commun Dis Rep       Date:  2022-04-06

10.  Identifying and describing a cohort effect in the national database of reported cases of hepatitis C virus infection in Canada (1991-2010): an age-period-cohort analysis.

Authors:  Max Trubnikov; Ping Yan; Jane Njihia; Chris Archibald
Journal:  CMAJ Open       Date:  2014-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.